Literature DB >> 35200130

Incidence, prevalence and mortality of chronic periaortitis: a population-based study.

Matthew J Koster1, Umar Ghaffar2, Stephanie Q Duong3, Cynthia S Crowson4, Michelle M Burke2, Boyd R Viers5, Aaron M Potretzke5, Haraldur Bjarnason6, Kenneth J Warrington2.   

Abstract

OBJECTIVES: To evaluate the epidemiology, presentation and outcomes of patients with chronic periaortitis from 1998 through 2018.
METHODS: An inception cohort of patients with incident chronic periaortitis from January 1, 1998 through December 31, 2018, in Olmsted County, Minnesota was identified based on comprehensive individual medical record review utilising the Rochester Epidemiology Project medical record linkage system. Inclusion required radiographic and/or histologic confirmation of periarterial soft tissue thickening around at least part of the infra-renal abdominal aorta or the common iliac arteries. Data were collected on demographic characteristics, clinical presentation, renal and radiographic outcomes, and mortality. Incidence rates were age and sex adjusted to the 2010 United States white population.
RESULTS: Eleven incident cases of chronic periaortitis were identified during the study period. Average age at diagnosis was 61.8±13.4 years. The cohort included 9 men (82%) and 2 women (18%). Age- and sex-adjusted incidence rates per 100,000 population were 0.26 for females, 1.56 for males and 0.87 overall. Overall prevalence on January 1, 2015 was 8.98 per 100,000 population. Median (IQR) length of follow-up was 10.1 (2.5, 13.8) years. Overall mortality was similar to the expected age, sex, and calendar estimates of the Minnesota population with standardised mortality ratio (95% CI) for the entire cohort 2.07 (0.67, 4.84).
CONCLUSIONS: This study reports the first epidemiologic data on chronic periaortitis in the United States. In this cohort of patients with chronic periaortitis, men were 4 times more commonly affected than women. Mortality was not increased compared to the general population.

Entities:  

Mesh:

Year:  2022        PMID: 35200130      PMCID: PMC9468868          DOI: 10.55563/clinexprheumatol/0v8l4j

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.862


  27 in total

Review 1.  Retroperitoneal fibrosis due to Wegener's granulomatosis: a misdiagnosis as tuberculosis.

Authors:  Hassane Izzedine; Aude Servais; Vincent Launay-Vacher; Gilbert Deray
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

Review 2.  Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of literature.

Authors:  Hang Liu; Gejun Zhang; Yimeng Niu; Nan Jiang; Weiguo Xiao
Journal:  Rheumatol Int       Date:  2014-04-23       Impact factor: 2.631

3.  Systemic lupus erythematosus with signs of retroperitoneal fibrosis.

Authors:  D D Lloyd; J W Balfe; M Barkin; E W Gelfand
Journal:  J Pediatr       Date:  1974-08       Impact factor: 4.406

4.  Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes.

Authors:  Tanaz A Kermani; Cynthia S Crowson; Sara J Achenbach; Harvinder S Luthra
Journal:  Mayo Clin Proc       Date:  2011-04       Impact factor: 7.616

Review 5.  Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature.

Authors:  K Warnatz; A G Keskin; M Uhl; C Scholz; A Katzenwadel; P Vaith; H H Peter; U A Walker
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

6.  Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation.

Authors:  E F H van Bommel; I Jansen; T R Hendriksz; A L H J Aarnoudse
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

7.  Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone.

Authors:  Eric F H van Bommel; Claire Siemes; Liesbeth E Hak; Sacha J van der Veer; Tadek R Hendriksz
Journal:  Am J Kidney Dis       Date:  2007-05       Impact factor: 8.860

8.  Asbestos exposure as a risk factor for retroperitoneal fibrosis.

Authors:  Toomas Uibu; Panu Oksa; Anssi Auvinen; Eero Honkanen; Kaj Metsärinne; Heikki Saha; Jukka Uitti; Pekka Roto
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

Review 9.  Chronic periaortitis: a fibro-inflammatory disorder.

Authors:  Alessandra Palmisano; Augusto Vaglio
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-06       Impact factor: 4.098

10.  The clinical significance of retroperitoneal fibrosis.

Authors:  L Koep; G D Zuidema
Journal:  Surgery       Date:  1977-03       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.